Perspectives on nucleolar DNA damage response in the fight against cancer

Cancer, which affects so many people each year, relies on proteins to proliferate throughout the body. Scientists are damaging the disease’s protein factories as part of a new tactic to combat the widespread disease.

Perspectives on nucleolar DNA damage response in the fight against cancer
Shan Yan, UNC Charlotte. Image Credit: UNC Charlotte

Scientists from the University of North Carolina at Charlotte highlighted the emerging topic of nucleolar DNA damage response (DDR) pathways in a new forum paper published in Trends in Biology. The review focuses on six ways by which cells repair DNA damage, one of which was published in Nucleic Acids Research five months ago by the same authors. Future applied researchers will be able to impede cancer reproduction and growth by addressing these processes.

The whole purpose of the Trends paper is to bring attention to scientists in the field and trigger their research. I did not realize the significance of this field, which is only fifteen years old, until a couple of years ago.”

Shan Yan, Main Author, University of North Carolina at Charlotte

Scientists began the field in 2007 with the discovery of the first pathway within the nucleolus, a region within an organelle, or room, within the cell. Different chemicals within the nucleolus aid in the replication of DNA, which carries the instructions for cells. Glitches in the copies can be caused by a variety of reasons, including strand breaks.

The researchers discovered a method to help fix errors in ribosomal DNA or the instructions for the cell’s protein factories.

Investigators can aim against cancer by researching these systems, which rely on ribosomal DNA to produce the proteins required to attack the human body. For example, a Phase I clinical trial for a medicine that targets the second mechanism outlined in the study is already underway—if cancer cells cannot heal errors, they cannot form new factories, and thus cannot make new proteins.

Even though the first four mechanisms occur within the nucleolus, which is a room within the watery cell, the latter two mechanisms employ a unique cellular activity that was awarded the 2023 Breakthrough Prize in Life Sciences. Instead of staying inside a room, proteins pop up their own liquid “tents” to do their work in the process known as liquid–liquid phase transition.

Yan studied a protein called APE1 before working on the nucleolar DDR. When he realized that APE1 could detect the nucleolus within a cell and also pop up these liquid tents to accomplish work, it sparked his interest in these pathways and eventually led to the review paper.

What's new is that APE1 acts like a GPS or a first responder. It says there’s a problem here, we need a police car, a medic, and others to come and be concentrated here.”

Shan Yan, Main Author, University of North Carolina at Charlotte

Basic investigators like Yan will work to improve these systems, which will subsequently be used as areas of attack in the cancer fight by more applied scientists.

This is an exciting and emerging area. By testing this idea, and if the clinical trial is successful, then these mechanisms will be tickets into new clinical trials and treatments.”

Shan Yan, Main Author, University of North Carolina at Charlotte

Source:
Journal reference:

Li, J. & Yan, S. (2023). Molecular mechanisms of nucleolar DNA damage checkpoint response. Trends in Cell Biology. doi.org/10.1016/j.tcb.2023.02.003.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Insights Into PARP1 Biology Could Open Avenues to Improve Cancer Treatments